OT
OTR Therapeutics at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
OTR Therapeutics brings 2 presentations to ENA 2026 in Barcelona. Its posters cover an epigenetic drug for combination use and a RIPTAC molecule. OTR-8100, a potent and selective EED inhibitor, works in synergy with targeted therapies in solid tumors, and a next-generation AR-BRD4 RIPTAC shows greater potency and selectivity in AR-positive tumors.
| Organization | ENA 2026 Attendance |
|---|---|
OT OTR Therapeutics Shanghai, China | |
Clinical-stage biotech developing oncology drugs, including an EED inhibitor and RIPTAC molecules. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from OTR Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction